Boston Scientific Corp. (BSX)
Boston Scientific Corporation (BSX) is a global medical device company specializing in innovative healthcare solutions. Founded in 1979, it develops and manufactures devices for cardiovascular, respiratory, digestive, and other medical conditions, focusing on minimally invasive procedures and improving patient outcomes.
Company News
Boston Scientific announced its acquisition of Nalu Medical, a privately held medical device company specializing in chronic pain treatment, for $600 million. The deal is expected to close in the first half of 2026 and is projected to generate over $60 million in revenue by 2025.
The article explores three healthcare stocks leveraging artificial intelligence to improve efficiency, patient outcomes, and administrative processes in the medical sector, highlighting how AI is transforming healthcare delivery.
SoCalBio's 27th Annual Investor & Partnership Conference will feature keynote speeches by SetPoint Medical's CEO and former Axonics CEO, highlighting innovations in medical technology and neuroimmune modulation therapy for autoimmune diseases.
Baxter International Inc. reported better-than-expected Q2 2024 earnings, with adjusted EPS of 68 cents beating the consensus estimate. Revenue also topped expectations, driven by growth across the company's business segments. The company provided positive guidance for Q3 and full-year 2024.
The company is planning to file for regulatory approval of a label expansion for Ozempic in the U.S. and European Union in 2024.
